Evaluation of novel adhesive film containing ketorolac for post-surgery pain control: A safety and efficacy study

Journal of Periodontology

Volumn 82, Issue 7, 2011, Pages 963-968

  Al Hezaimi, Khalid ^a   Al Askar, Mansour ^a   Selamhe, Zuied ^a   Fu, Jia Hui ^b   Alsarra, Ibrahim A ^c   Wang, Hom Lay ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Adhesives; Anti inflammatory agents; Ketorolac; Non steroidal; Pain; Periodontal diseases; Surgery

Indexed keywords

ACRYLIC ACID RESIN; BIOPOLYMER; CARBOPOL 940; DRUG CARRIER; DRUG DERIVATIVE; HYDROXYPROPYLMETHYLCELLULOSE; KETOROLAC TROMETAMOL; METHYLCELLULOSE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; FEMALE; FOLLOW UP; GEL; GINGIVA; GINGIVA DISEASE; HUMAN; MALE; MIDDLE AGED; PAIN ASSESSMENT; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; SAFETY; TOPICAL DRUG ADMINISTRATION; TRANSPLANTATION; TREATMENT OUTCOME;

ACRYLIC RESINS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPOLYMERS; DOUBLE-BLIND METHOD; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; GELS; GINGIVA; GINGIVAL DISEASES; GINGIVAL RECESSION; HUMANS; KETOROLAC TROMETHAMINE; MALE; METHYLCELLULOSE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PLACEBOS; SAFETY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960510159     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.100553     Document Type: Article

References (22)

1. Wessel JR, Tatakis DN. Patient outcomes following subepithelial connective tissue graft and free gingival graft procedures. J Periodontol 2008;79:425-430.
2. Griffin TJ, Cheung WS, Zavras AI, Damoulis PD. Postoperative complications following gingival augmentation procedures. J Periodontol 2006;77:2070-2079. (Pubitemid 46002088)
3. Pihlstrom BL, Hargreaves KM, Bouwsma OJ, Myers WR, Goodale MB, Doyle MJ. Pain after periodontal scaling and root planing. J Am Dent Assoc 1999;130:801-807.
4. Fitzgerald DJ, Maree A. Aspirin and clopidogrel resistance. Hematology Am Soc Hematol Educ Program 2007:114-120.
5. Mroszczak EJ, Jung D, Yee J, Bynum L, Sevelius H, Massey I. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy 1990;10:33S-39S.
6. Buckley MM, Brogden RN. Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1990;39:86-109.
7. Alanazi FA, Rahman AAA, Mahrous GM, Alsarra IA. Formulation and physicochemical characterization of buccaadhesive films containing ketorolac. J Drug Del Sci Tech 2007;17:183-192. (Pubitemid 47057011)
8. Walton GM, Rood JP, Snowdon AT, Rickwood D. Ketorolac and diclofenac for postoperative pain relief following oral surgery. Br J Oral Maxillofac Surg 1993; 31:158-160. (Pubitemid 23177372)
9. Pilotto A, Franceschi M, Leandro G, et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: The role of gastroprotective drugs. Aging Clin Exp Res 2003;15:494-499. (Pubitemid 38180788)
10. Olmedo MV, Gálvez R, Vallecillo M. Double-blind parallel comparison of multiple doses of ketorolac, ketoprofen and placebo administered orally to patients with postoperative dental pain. Pain 2001;90:135-141. (Pubitemid 32146566)
11. Roy SD, Manoukian E. Transdermal delivery of ketorolac tromethamine: Permeation enhancement, device design, and pharmacokinetics in healthy humans. J Pharm Sci 1995;84:1190-1196.
12. Amrish C, Kumar SP. Transdermal delivery of ketorolac. Yakugaku Zasshi 2009;129:373-379.
13. Cho YA, Gwak HS. Transdermal delivery of ketorolac tromethamine: Effects of vehicles and penetration enhancers. Drug Dev Ind Pharm 2004;30:557-564. (Pubitemid 38924625)
14. Tiwari SB, Pai RM, Udupa N. Influence of ultrasound on the percutaneous absorption of ketorolac tromethamine in vitro across rat skin. Drug Deliv 2004;11:47-51. (Pubitemid 38292727)
15. Santus G, Rivolta R, Bottoni G, Testa B, Canali S, Peano S. Nasal formulations of ketorolac tromethamine: Technological evaluation -Bioavailability and tolerability in rabbits. Farmaco 1993;48:1709-1723. (Pubitemid 24070301)
16. Chelladurai S, Mishra M, Mishra B. Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine. Chem Pharm Bull (Tokyo) 2008;56: 1596-1599.
17. Cordero JA, Camacho M, Obach R, Domenech J, Vila L. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur J Pharm Biopharm 2001;51:135-142. (Pubitemid 32162492)
18. Perry HD, Donnenfeld ED. An update on the use of ophthalmic ketorolac tromethamine 0.4%. Expert Opin Pharmacother 2006;7:99-107. (Pubitemid 43056426)
19. Jeffcoat MK, Reddy MS, Haigh S, et al. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 1995;66:329-338.
20. Mulshine JL, Atkinson JC, Greer RO, et al. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res 2004; 10:1565-1573. (Pubitemid 38435544)
21. Alsarra IA, Alanazi FK, Mahrous GM, Abdel Rahman AA, Al Hezaimi KA. Clinical evaluation of novel buccoadhesive film containing ketorolac in dental and post-oral surgery pain management. Pharmazie 2007; 62:773-778. (Pubitemid 47608026)
22. Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: Swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci 1999;2:53-61.